Gilberto L. Pardo-Andreu
State University of Campinas
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Gilberto L. Pardo-Andreu.
Pharmacological Research | 2008
Gilberto L. Pardo-Andreu; Mariela Forrellat Barrios; Carlos Curti; Ivones Hernández; Nelson Merino; Yeny Lemus; Ioanna Martínez; Annia Riaño; René Delgado
In vivo preventive effects of a Mangifera indica L extract (Vimang) or its major component mangiferin on iron overload injury have been studied in rats given respectively, 50, 100, 250 mg kg(-1) body weight of Vimang, or 40 mg kg(-1) body weight of mangiferin, for 7 days prior to, and for 7 days following the administration of toxic amounts of iron-dextran. Both Vimang or mangiferin treatment prevented iron overload in serum as well as liver oxidative stress, decreased serum and liver lipid peroxidation, serum GPx activity, and increased serum and liver GSH, serum SOD and the animals overall antioxidant condition. Serum iron concentration was decreased although at higher doses, Vimang tended to increase it; percent tranferrin saturation, liver weight/body mass ratios, liver iron content was decreased. Treatment increased serum iron-binding capacity and decreased serum levels of aspartate-amine transferase (ASAT) and alanine-amine transferase (ALAT), as well as the number of abnormal Kupffer cells in iron-loaded livers. It is suggested that besides acting as antioxidants, Vimang extract or its mangiferin component decrease liver iron by increasing its excretion. Complementing earlier in vitro results from our group, it appears possible to support the hypothesis that Vimang and mangiferin present therapeutically useful effects in iron overload related diseases.
Pharmacological Research | 2008
Gilberto L. Pardo-Andreu; Bruno A. Paim; Roger F. Castilho; Jesus A. Velho; René Delgado; Anibal E. Vercesi; Helena C. F. Oliveira
Atherosclerosis is linked to a number of oxidative events ranging from low-density lipoprotein (LDL) oxidation to the increased production of intracellular reactive oxygen species (ROS). We have recently demonstrated that liver mitochondria isolated from the atherosclerosis-prone hypercholesterolemic LDL receptor knockout (LDLr(-/-)) mice have lower content of NADP(H)-linked substrates than the controls and, as consequence, higher sensitivity to oxidative stress and mitochondrial membrane permeability transition (MPT). In the present work, we show that oral supplementation with the antioxidants Mangifera indica L. extract (Vimang) or its main polyphenol mangiferin shifted the sensitivity of LDLr(-/-) liver mitochondria to MPT to control levels. These in vivo treatments with Vimang and mangiferin also significantly reduced ROS generation by both isolated LDLr(-/-) liver mitochondria and spleen lymphocytes. In addition, these antioxidant treatments prevented mitochondrial NAD(P)H-linked substrates depletion and NADPH spontaneous oxidation. In summary, Vimang and mangiferin spared the endogenous reducing equivalents (NADPH) in LDLr(-/-) mice mitochondria correcting their lower antioxidant capacity and restoring the organelle redox homeostasis. The effective bioavailability of these compounds makes them suitable antioxidants with potential use in atherosclerosis susceptible conditions.
Journal of Pharmacology and Experimental Therapeutics | 2006
Gilberto L. Pardo-Andreu; Renata A. Cavalheiro; Daniel Junqueira Dorta; Zeki Naal; René Delgado; Anibal E. Vercesi; Carlos Curti
Mangiferin acts as a strong antioxidant on mitochondria. However, when in the presence of Ca2+, mangiferin elicits mitochondrial permeability transition (MPT), as evidenced by cyclosporin A-sensitive mitochondrial swelling. We now provide evidence, by means of electrochemical and UV-visible spectroscopical analysis, that Fe(III) coordinates with mangiferin. The resulting mangiferin-Fe(III) complex does not elicit MPT and prevents MPT by scavenging reactive oxygen species. Indeed, the complex protects mitochondrial membrane protein thiols and glutathione from oxidation. Fe(III) also significantly increases the ability of mangiferin to scavenge the 2,2-diphenyl-1-picrylhydrazyl radical, as well as to display antioxidant activity toward antimycin A-induced H2O2 production and t-butyl hydroperoxide-promoted membrane lipid peroxidation in mitochondria. We postulate that coordination with Fe(III) constitutes a potential protective mechanism toward the prooxidant action of mangiferin and other catechol-containing antioxidants regarding MPT induction. Potential therapeutic relevance of this finding for conditions of pathological iron overload is discussed.
Phytotherapy Research | 2009
Thales Preissler; Márcio R. Martins; Gilberto L. Pardo-Andreu; João Antonio Pêgas Henriques; João Quevedo; René Delgado; Rafael Roesler
Vimang is an aqueous extract of Mangifera indica L, used in Cuba for the treatment of immunopathological disorders. Increasing evidence from preclinical studies indicates that Vimang displays antioxidant, antiallergic, analgesic and antiinflammatory actions. The present study investigated the effects of systemic administration of Vimang on behavioural outcomes of neurological function in rats. A single oral administration of Vimang produced an impairment of short‐ and long‐term retention of memory for aversive training when given either 1 h pretraining or immediately posttraining, but not 8 h posttraining. Vimang did not affect open field behaviour or habituation. The results indicate that Vimang might induce deficits of emotionally motivated memory without affecting nonassociative memory, locomotion, exploratory behaviour or anxiety. Copyright
Archives of Medical Research | 2006
Gilberto L. Pardo-Andreu; Sarah J. Philip; Annia Riaño; Carlos Sánchez; Carmen Viada; Alberto J. Núñez-Sellés; René Delgado
Pharmacological Research | 2007
Alberto J. Núñez-Sellés; René Delgado-Hernández; Gabino Garrido-Garrido; Dagmar García-Rivera; Mariela Guevara-García; Gilberto L. Pardo-Andreu
Toxicology in Vitro | 2007
Andrés Revilla; Cezar R. Pestana; Gilberto L. Pardo-Andreu; Antonio C. Santos; Sérgio A. Uyemura; María E. Gonzales; Carlos Curti
Pharmacological Research | 2006
Gilberto L. Pardo-Andreu; René Delgado; Alberto J. Núñez-Sellés; Anibal E. Vercesi
Phytotherapy Research | 2006
Gilberto L. Pardo-Andreu; René Delgado; Alberto J. Núñez-Sellés; Anibal E. Vercesi
Pharmacological Research | 2007
Alberto J. Núñez-Sellés; René Delgado-Hernández; Gabino Garrido-Garrido; Dagmar García-Rivera; Mariela Guevara-García; Gilberto L. Pardo-Andreu